Materias dentro de su búsqueda.
Mostrando 81 - 100 Resultados de 312 Para Buscar '"Gavi"', tiempo de consulta: 0.12s Limitar resultados
  1. 81
    “…These countries are not eligible for Gavi support in accessing new vaccines because of their relatively high per capita income level and will gradually increase with the transitioning of countries out of Gavi support. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improving access to affordable vaccines for middle-income countries in the african region
  2. 82
    “…INTERPRETATION: Our findings highlight the value of Gavi's support for PCV introduction in low-income countries and of efforts to improve the affordability of PCVs in countries not eligible for, or transitioning from, Gavi support. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
  3. 83
    “…Base case costs were estimated from the government perspective, assuming Gavi subsidies, over the first five years. We also present estimates from the cost of vaccination from the perspective of Gavi. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria
  4. 84
    “…Participants highlighted that the change in the macro-economic environment following the 2008 financial crisis affected national policy in donor countries and subsequently the number of new commitments IFFIm received. Since Gavi is now seen as a successful and mature organization, participants stated that donors prefer to donate directly to Gavi. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The International Finance Facility for Immunisation: stakeholders’ perspectives
  5. 85
    “…Ghana’s transition from low to lower-middle income status in 2010 implies fewer resources from Gavi as well as other major global financing mechanisms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
  6. 86
    “…We varied the expected price (with and without Gavi subsidy), wastage, and incremental health system costs associated with each vaccine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
  7. 87
    “…PURPOSE: This study compared Gavi(®), an automated system for the equilibration and dehydration steps of vitrification, and a manual vitrification procedure in terms of effects on clinical outcomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Equivalent clinical outcome after vitrified‐thawed blastocyst transfer using semi‐automated embryo vitrification system compared with manual vitrification method
  8. 88
    “…In 2016, the Gavi Cold Chain Equipment Optimization Platform (CCEOP) was approved and launched in recognition of the fact that functional cold chain equipment (CCE) is essential to strengthening vaccine supply chains and ultimately achieving Gavi’s immunization equity and coverage goals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Tale of 2 Countries: Implementation of the Cold Chain Equipment Optimization Platform in Guinea and Kenya
  9. 89
    “…In multivariable models that control for Gross National Income, region, and burden of Hib disease, the receipt of GAVI support speeded the time to decision by a factor of 0.37 (95% CI 0.18–0.76), or 63%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Accelerating Policy Decisions to Adopt Haemophilus influenzae Type b Vaccine: A Global, Multivariable Analysis
  10. 90
    “…BACKGROUND: The World Health Organization (WHO) released a position paper in March 2018 calling for integration of a novel typhoid conjugate vaccine (TCV) into routine immunization along with catch-up campaigns for children up to age 15. Gavi, the Vaccine Alliance, has committed funding to help resource-constrained countries introduce this vaccine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries
  11. 91
    “…HPV vaccination has not been introduced nationally and Gavi co-financing support is not available in Mongolia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The potential cost-effectiveness of HPV vaccination among girls in Mongolia
  12. 92
    “…India is introducing several new vaccines including some supported by Gavi. Therefore, the government will have to ensure that additional resources will be made available after the support from Gavi ceases.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Determinants of cost of routine immunization programme in India
  13. 93
    por Davies, Sara E.
    Publicado 2016
    “…In particular, there have been growing claims that the successful global health initiatives such as, the Global Fund for AIDS, TB, and Malaria (Global Fund) and the Global Alliance for Vaccine Immunization (GAVI) were achieved without asserting their necessity on security considerations. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Advocating Global Health Security
  14. 94
    por Johnson, Barbara Wilmot, Demanou, Maurice, Fall, Gamou, Betoulle, Jean-Luc, Obiekea, Celestina, Basile, Alison Jane, Domingo, Cristina, Goodman, Christin, Mossel, Eric, Reusken, Chantal, Staples, Erin, de Morais, Joana Filipa Machado, Neto, Zoraima, Paixão, Paula, Denon, Yves Eric, Glitho, Mariette, Mahinou, José, Kagone, Therese, Nakoune, Emmanuel, Gamougam, Kadidja, Simbu, Elisabeth Pukuta, Ahuka, Steve, Mombouli, Jean-Vivien, Goma-Nkoua, Cynthia, Adjogoua, Edgard Valery, Tayachew, Adamu, Beyene, Berhane, Sanneh, Bakary, Jarju, Modou Lamin, Mendy, Alphonse, Amelor, Dodzi Kofi, Ofosu-Appiah, Lawrence, Opare, David, Antwi, Lorreta, Adade, Rexford, Magassouba, N'Faly, Gomes, Sabado Fernandes, Limbaso, Samson, Lutomiah, Joel, Gbelee, Burgess, Dogba, John, Cisse, Issa, Idde, Zakou, Ihekweazu, Chikwe, Mba, Nwando, Faye, Ousmane, Faye, Oumar, Sall, Amadou Alpha, Koroma, Zikan, Juma, Manuela Alphonse, Maror, James Ayei, Eldigail, Mawahib, Elduma, Adel Hussein, Elageb, Rehab, Badziklou, Kossi, Komla, Koba Adjaho, Kayiwa, John, Lutwama, Julius Julian, Hampton, Lee, Mulders, Mick Norman
    Publicado 2021
    “…CONCLUSION: the laboratory assessments helped to document the baseline capacities of these laboratories prior to Gavi funding to support strengthening YF laboratories.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018
  15. 95
    “…Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Gavi, the Vaccine Alliance (Gavi). An economic evaluation of HPV vaccination is required to help sustain investment and inform decisions about optimal HPV vaccine choices. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
  16. 96
    “…Four additional countries (Angola, Indonesia, Philippines, and Vietnam) do not have allocations from Gavi, the Vaccine Alliance for Health Systems Strengthening, or Equity Accelerator Funding, but are eligible for support under Gavi’s Middle-Income Countries Approach. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recovery of Routine Immunisation: Mapping External Financing Opportunities for Reaching Zero-Dose Children
  17. 97
    “…After the unprecedented success and acceleration of the global agenda towards typhoid fever control with a strong World Health Organization recommendation and the approval of funding from Gavi, the Vaccine Alliance (Gavi), for the use of a new typhoid conjugate vaccine (TCV), we should turn our minds to the challenges that remain ahead. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
  18. 98
    “…CONCLUSIONS: It is important that the other countries eligible for Gavi support that are about to change to the multi-dose vial PCV13 presentation learn from Benin’s experience. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience
  19. 99
    “…Both interventions were evaluated at US$3 and US$5 per dose for Gavi and non-Gavi countries, respectively. A range of input values were considered to explore uncertainty. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
  20. 100
    “…BACKGROUND: Post-exposure prophylaxis (PEP) is highly effective at preventing human rabies deaths, however access to PEP is limited in many rabies endemic countries. The 2018 decision by Gavi to add human rabies vaccine to its investment portfolio should expand PEP availability and reduce rabies deaths. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How geographic access to care shapes disease burden: The current impact of post-exposure prophylaxis and potential for expanded access to prevent human rabies deaths in Madagascar
Herramientas de búsqueda: RSS